PBM

Propel Bio Management Portfolio holdings

AUM $82.4M
1-Year Est. Return 29.33%
This Quarter Est. Return
1 Year Est. Return
+29.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$101M
AUM Growth
-$71.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
23
New
Increased
Reduced
Closed

Top Buys

1
+$2.61M
2
+$974K
3
+$661K
4
JSPR icon
Jasper Therapeutics
JSPR
+$428K
5
DCTH icon
Delcath Systems
DCTH
+$205K

Top Sells

1
+$4.82M
2
+$608K
3
+$500K
4
CMPS
Compass Pathways
CMPS
+$207K

Sector Composition

1 Healthcare 76.74%
2 Energy 23.23%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$23.4M 23.23%
1,272,360
2
$13.3M 13.19%
43,032
3
$9.56M 9.5%
343,729
4
$8.63M 8.58%
2,453,092
5
$8.23M 8.18%
9,615,420
+3,047,562
6
$8.04M 7.98%
989,927
+120,000
7
$6.34M 6.3%
2,087,139
8
$5.19M 5.16%
178,500
9
$4.82M 4.79%
950,947
-120,000
10
$3.48M 3.45%
624,022
11
$2.42M 2.41%
183,259
+50,000
12
$2.27M 2.25%
56,359
13
$1.5M 1.49%
179,874
14
$1.13M 1.12%
130,000
15
$876K 0.87%
1,492,792
16
$765K 0.76%
146,381
17
$428K 0.42%
+20,000
18
$205K 0.2%
+17,000
19
$95.3K 0.09%
25,209
-54,791
20
– –
-365,781
21
– –
-34,494